About
CellCipher develops scalable human in vitro models and applies single-cell genomics combined with machine learning to improve the prediction of drug responses and toxicities, aiming to enhance preclinical drug development and precision medicine.
Explore cellcipher's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.